Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper

Response evaluation criteria in solid tumours (RECIST) v1.1 are currently the reference standard for evaluating efficacy of therapies in patients with solid tumours who are included in clinical trials, and they are widely used and accepted by regulatory agencies. This expert statement discusses the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fournier, Laure, de Geus-Oei, Lioe-Fee, Regge, Daniele, Oprea-Lager, Daniela-Elena, D’Anastasi, Melvin, Bidaut, Luc, Bäuerle, Tobias, Lopci, Egesta, Cappello, Giovanni, Lecouvet, Frederic, Mayerhoefer, Marius, Kunz, Wolfgang G., Verhoeff, Joost J. C., Caruso, Damiano, Smits, Marion, Hoffmann, Ralf-Thorsten, Gourtsoyianni, Sofia, Beets-Tan, Regina, Neri, Emanuele, deSouza, Nandita M., Deroose, Christophe M., Caramella, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784734/
https://www.ncbi.nlm.nih.gov/pubmed/35083155
http://dx.doi.org/10.3389/fonc.2021.800547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784734/
https://www.ncbi.nlm.nih.gov/pubmed/35083155
http://dx.doi.org/10.3389/fonc.2021.800547

Ejemplares similares